RA PHARMACEUTICALS, INC. Retained Earnings
RA PHARMACEUTICALS, INC. had Retained Earnings of -$290.85 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-02-27
- 2019-12-31: Retained Earnings (Accumulated Deficit) -$290.85M.
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$254.07M.
- 2019-06-30: Retained Earnings (Accumulated Deficit) -$229.09M.
- 2019-03-31: Retained Earnings (Accumulated Deficit) -$207.20M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2019-12-31 | -$290.85M 10-K · filed 2020-02-27 |
| 2019-09-30 | -$254.07M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$229.09M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$207.20M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$188.16M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$171.96M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$155.46M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$139.71M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$123.21M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$108.07M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$92.80M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$80.14M 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$68.76M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$57.88M 10-Q · filed 2016-11-29 |
| 2015-12-31 | -$39.90M 10-K · filed 2017-03-06 |